All the relevant trial data has been submitted to WHO, and all clarifications by the UN health agency have been responded to Bharat Biotech.
WHO’s emergency use authorisation for Covaxin further delayed: Sources
By News Analysis India1 Min Read
Related Posts
Add A Comment